537 related articles for article (PubMed ID: 30545317)
1. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract.
Bidossi A; De Grandi R; Toscano M; Bottagisio M; De Vecchi E; Gelardi M; Drago L
BMC Infect Dis; 2018 Dec; 18(1):653. PubMed ID: 30545317
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and tolerability of Streptococcus salivarius 24SMB and Streptococcus oralis 89a administered as nasal spray in the treatment of recurrent upper respiratory tract infections in children.
Passali D; Passali GC; Vesperini E; Cocca S; Visconti IC; Ralli M; Bellussi LM
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(1 Suppl):67-72. PubMed ID: 30920629
[TBL] [Abstract][Full Text] [Related]
3. Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy.
Manti S; Parisi GF; Papale M; Licari A; Salpietro C; Miraglia Del Giudice M; Marseglia GL; Leonardi S
Ital J Pediatr; 2020 Apr; 46(1):42. PubMed ID: 32245500
[TBL] [Abstract][Full Text] [Related]
4. Preventing recurrent acute otitis media with Streptococcus salivarius 24SMB and Streptococcus oralis 89a five months intermittent treatment: An observational prospective cohort study.
Cantarutti A; Rea F; Donà D; Cantarutti L; Passarella A; Scamarcia A; Lundin R; Damiani V; Giaquinto C; Corrao G
Int J Pediatr Otorhinolaryngol; 2020 May; 132():109921. PubMed ID: 32062496
[TBL] [Abstract][Full Text] [Related]
5. Putative Microbial Population Shifts Attributable to Nasal Administration of Streptococcus salivarius 24SMBc and Streptococcus oralis 89a.
De Grandi R; Drago L; Bidossi A; Bottagisio M; Gelardi M; De Vecchi E
Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1219-1226. PubMed ID: 30535674
[TBL] [Abstract][Full Text] [Related]
6. Modulation of opportunistic species Corynebacterium diphtheriae, Haemophilus parainfluenzae, Moraxella catarrhalis, Prevotella denticola, Prevotella melaninogenica, Rothia dentocariosa, Staphylococcus aureus and Streptococcus pseudopneumoniae by intranasal administration of Streptococcus salivarius 24SMBc and Streptococcus oralis 89a combination in healthy subjects.
De Grandi R; Bottagisio M; Di Girolamo S; Bidossi A; De Vecchi E; Drago L
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(1 Suppl):60-66. PubMed ID: 30920634
[TBL] [Abstract][Full Text] [Related]
7. Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study.
Andaloro C; Santagati M; Stefani S; La Mantia I
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):879-887. PubMed ID: 30767047
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms.
Humphreys GJ; McBain AJ
Lett Appl Microbiol; 2019 Apr; 68(4):303-312. PubMed ID: 30776138
[TBL] [Abstract][Full Text] [Related]
9. Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection.
Fiedler T; Riani C; Koczan D; Standar K; Kreikemeyer B; Podbielski A
Appl Environ Microbiol; 2013 Feb; 79(4):1265-76. PubMed ID: 23241973
[TBL] [Abstract][Full Text] [Related]
10. Bacteriotherapy with
La Mantia I; Varricchio A; Ciprandi G
Int J Gen Med; 2017; 10():171-175. PubMed ID: 28684920
[TBL] [Abstract][Full Text] [Related]
11. Bacteriotherapy in children with recurrent upper respiratory tract infections.
Tarantino V; Savaia V; D'Agostino R; Silvestri M; Passali FM; Di Girolamo S; Ciprandi G
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(1 Suppl):39-43. PubMed ID: 30920639
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus oralis maintains homeostasis in oral biofilms by antagonizing the cariogenic pathogen Streptococcus mutans.
Thurnheer T; Belibasakis GN
Mol Oral Microbiol; 2018 Jun; 33(3):234-239. PubMed ID: 29327482
[TBL] [Abstract][Full Text] [Related]
13. Bacteriotherapy for preventing recurrent upper respiratory infections in children: a real-world experience.
Tarantino V; Savaia V; D'Agostino R; Silvestri M; Ciprandi G
Otolaryngol Pol; 2018 May; 72(3):33-38. PubMed ID: 29989557
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus salivarius 24SMB administered by nasal spray for the prevention of acute otitis media in otitis-prone children.
Marchisio P; Santagati M; Scillato M; Baggi E; Fattizzo M; Rosazza C; Stefani S; Esposito S; Principi N
Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2377-83. PubMed ID: 26385346
[TBL] [Abstract][Full Text] [Related]
15. Local Bacteriotherapy - a promising preventive tool in recurrent respiratory infections.
Ciprandi G; La Mantia I; Damiani V; Passali D
Expert Rev Clin Immunol; 2020 Nov; 16(11):1047-1052. PubMed ID: 33022191
[TBL] [Abstract][Full Text] [Related]
16. Interactions between Streptococcus oralis, Actinomyces oris, and Candida albicans in the development of multispecies oral microbial biofilms on salivary pellicle.
Cavalcanti IM; Del Bel Cury AA; Jenkinson HF; Nobbs AH
Mol Oral Microbiol; 2017 Feb; 32(1):60-73. PubMed ID: 26834007
[TBL] [Abstract][Full Text] [Related]
17. The role of bacteriotherapy in the prevention of adenoidectomy.
La Mantia I; Varricchio A; Di Girolamo S; Minni A; Passali GC; Ciprandi G
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(1 Suppl):44-47. PubMed ID: 30920631
[TBL] [Abstract][Full Text] [Related]
18. Live and heat-killed Lactobacillus spp. interfere with Streptococcus mutans and Streptococcus oralis during biofilm development on titanium surface.
Ciandrini E; Campana R; Baffone W
Arch Oral Biol; 2017 Jun; 78():48-57. PubMed ID: 28193570
[TBL] [Abstract][Full Text] [Related]
19. Anti-bacterial and anti-biofilm activity of probiotic bacteria against oral pathogens.
Ben Taheur F; Kouidhi B; Fdhila K; Elabed H; Ben Slama R; Mahdouani K; Bakhrouf A; Chaieb K
Microb Pathog; 2016 Aug; 97():213-20. PubMed ID: 27317856
[TBL] [Abstract][Full Text] [Related]
20. The evidence for applying Streptococcus salivarius 24SMB by nasal spray for preventing recurrent acute otitis media.
Marchisio P; Esposito S; Principi N
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1889-1890. PubMed ID: 27461220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
